Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.901 | 3.17e-16 | 2.14e-04 | 1.90e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
PSMD2 | 5708 | 47 | -4.172 | 3.157 | 386 | Yes | Yes |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
GPAA1 | 8733 | 1 | -1.762 | 2.901 | 19 | - | - |
[ PRR13 ] | 54458 | 1 | -1.227 | 2.901 | 8 | - | - |
GPI | 2821 | 1 | -1.904 | 2.901 | 57 | - | - |
NAP1L4 | 4676 | 4 | -1.947 | 3.119 | 187 | - | - |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
GPAA1 | 8733 | PRR13 | 54458 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: MINT, StelzlLow, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
GPI | 2821 | NAP1L4 | 4676 | pp | -- | int.I2D: IntAct_Yeast |
DDIT3 | 1649 | NAP1L4 | 4676 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
GPI | 2821 | GPAA1 | 8733 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
GPI | 2821 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
DDIT3 | 1649 | GPI | 2821 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.69e-05 | 3.88e-01 | 7.946 | 2 | 2 | 13 |
GO:0044212 | transcription regulatory region DNA binding | 1.24e-04 | 1.00e+00 | 4.839 | 3 | 17 | 168 |
GO:0005654 | nucleoplasm | 2.30e-04 | 1.00e+00 | 2.889 | 5 | 64 | 1082 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0004347 | glucose-6-phosphate isomerase activity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0016866 | intramolecular transferase activity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0019242 | methylglyoxal biosynthetic process | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0060242 | contact inhibition | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0046185 | aldehyde catabolic process | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0060913 | cardiac cell fate determination | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0006355 | regulation of transcription, DNA-templated | 2.16e-03 | 1.00e+00 | 2.685 | 4 | 43 | 997 |
GO:0001714 | endodermal cell fate specification | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 2 | 5 |
GO:0003923 | GPI-anchor transamidase activity | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0042765 | GPI-anchor transamidase complex | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0006974 | cellular response to DNA damage stimulus | 3.74e-03 | 1.00e+00 | 4.408 | 2 | 7 | 151 |
GO:0070937 | CRD-mediated mRNA stability complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 |
GO:0048029 | monosaccharide binding | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 |
GO:0051156 | glucose 6-phosphate metabolic process | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0016255 | attachment of GPI anchor to protein | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0034235 | GPI anchor binding | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0006621 | protein retention in ER lumen | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0003714 | transcription corepressor activity | 5.15e-03 | 1.00e+00 | 4.170 | 2 | 11 | 178 |
GO:0006983 | ER overload response | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0007599 | hemostasis | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 2 | 9 |
GO:0005634 | nucleus | 5.94e-03 | 1.00e+00 | 1.299 | 7 | 159 | 4559 |
GO:0035413 | positive regulation of catenin import into nucleus | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 10 |
GO:0010467 | gene expression | 6.76e-03 | 1.00e+00 | 2.845 | 3 | 45 | 669 |
GO:0045662 | negative regulation of myoblast differentiation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 4 | 11 |
GO:0005838 | proteasome regulatory particle | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 13 |
GO:0001824 | blastocyst development | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 2 | 15 |
GO:0008134 | transcription factor binding | 9.34e-03 | 1.00e+00 | 3.727 | 2 | 18 | 242 |
GO:0042176 | regulation of protein catabolic process | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 16 |
GO:0005829 | cytosol | 1.05e-02 | 1.00e+00 | 1.683 | 5 | 86 | 2496 |
GO:0022624 | proteasome accessory complex | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 17 |
GO:0032757 | positive regulation of interleukin-8 production | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 20 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 22 |
GO:0016020 | membrane | 1.43e-02 | 1.00e+00 | 1.931 | 4 | 46 | 1681 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 23 |
GO:0035329 | hippo signaling | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 26 |
GO:0006501 | C-terminal protein lipidation | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 26 |
GO:0015631 | tubulin binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 27 |
GO:0043565 | sequence-specific DNA binding | 1.85e-02 | 1.00e+00 | 3.212 | 2 | 11 | 346 |
GO:0042594 | response to starvation | 1.92e-02 | 1.00e+00 | 5.692 | 1 | 4 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 32 |
GO:0007611 | learning or memory | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 34 |
GO:0006096 | glycolytic process | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 3 | 38 |
GO:0044822 | poly(A) RNA binding | 2.35e-02 | 1.00e+00 | 2.187 | 3 | 50 | 1056 |
GO:0035019 | somatic stem cell maintenance | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 6 | 40 |
GO:0006094 | gluconeogenesis | 2.65e-02 | 1.00e+00 | 5.220 | 1 | 1 | 43 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 4 | 46 |
GO:0006959 | humoral immune response | 2.90e-02 | 1.00e+00 | 5.092 | 1 | 3 | 47 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 1 | 51 |
GO:0009611 | response to wounding | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 5 | 52 |
GO:0005515 | protein binding | 3.23e-02 | 1.00e+00 | 0.897 | 7 | 198 | 6024 |
GO:0044267 | cellular protein metabolic process | 3.33e-02 | 1.00e+00 | 2.757 | 2 | 20 | 474 |
GO:0003677 | DNA binding | 3.43e-02 | 1.00e+00 | 1.981 | 3 | 49 | 1218 |
GO:0000502 | proteasome complex | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 3 | 58 |
GO:0006396 | RNA processing | 3.62e-02 | 1.00e+00 | 4.764 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.62e-02 | 1.00e+00 | 4.764 | 1 | 6 | 59 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 3.74e-02 | 1.00e+00 | 4.715 | 1 | 2 | 61 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3.86e-02 | 1.00e+00 | 4.669 | 1 | 4 | 63 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 2 | 70 |
GO:0006334 | nucleosome assembly | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 3 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 1 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 2 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 1 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 7 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 2 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 5.06e-02 | 1.00e+00 | 4.271 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 5.24e-02 | 1.00e+00 | 4.220 | 1 | 8 | 86 |
GO:0001649 | osteoblast differentiation | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 5 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 1 | 92 |
GO:0005770 | late endosome | 5.66e-02 | 1.00e+00 | 4.107 | 1 | 2 | 93 |
GO:0051082 | unfolded protein binding | 5.66e-02 | 1.00e+00 | 4.107 | 1 | 7 | 93 |
GO:0006461 | protein complex assembly | 6.72e-02 | 1.00e+00 | 3.852 | 1 | 4 | 111 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.73e-02 | 1.00e+00 | 2.197 | 2 | 39 | 699 |
GO:0030529 | ribonucleoprotein complex | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 5 | 112 |
GO:0000209 | protein polyubiquitination | 7.01e-02 | 1.00e+00 | 3.788 | 1 | 3 | 116 |
GO:0043524 | negative regulation of neuron apoptotic process | 7.07e-02 | 1.00e+00 | 3.776 | 1 | 5 | 117 |
GO:0006006 | glucose metabolic process | 7.13e-02 | 1.00e+00 | 3.764 | 1 | 5 | 118 |
GO:0007050 | cell cycle arrest | 7.48e-02 | 1.00e+00 | 3.692 | 1 | 5 | 124 |
GO:0016055 | Wnt signaling pathway | 8.29e-02 | 1.00e+00 | 3.538 | 1 | 4 | 138 |
GO:0005125 | cytokine activity | 8.29e-02 | 1.00e+00 | 3.538 | 1 | 2 | 138 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.33e-02 | 1.00e+00 | 2.022 | 2 | 41 | 789 |
GO:0008083 | growth factor activity | 8.46e-02 | 1.00e+00 | 3.507 | 1 | 3 | 141 |
GO:0000082 | G1/S transition of mitotic cell cycle | 8.92e-02 | 1.00e+00 | 3.427 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 8.98e-02 | 1.00e+00 | 3.417 | 1 | 4 | 150 |
GO:0043005 | neuron projection | 9.38e-02 | 1.00e+00 | 3.352 | 1 | 3 | 157 |
GO:0043687 | post-translational protein modification | 9.67e-02 | 1.00e+00 | 3.306 | 1 | 5 | 162 |
GO:0000398 | mRNA splicing, via spliceosome | 9.78e-02 | 1.00e+00 | 3.289 | 1 | 15 | 164 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.02e-01 | 1.00e+00 | 3.228 | 1 | 2 | 171 |
GO:0005667 | transcription factor complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.06e-01 | 1.00e+00 | 3.170 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 22 | 184 |
GO:0001525 | angiogenesis | 1.13e-01 | 1.00e+00 | 3.069 | 1 | 7 | 191 |
GO:0016071 | mRNA metabolic process | 1.31e-01 | 1.00e+00 | 2.845 | 1 | 8 | 223 |
GO:0008380 | RNA splicing | 1.34e-01 | 1.00e+00 | 2.813 | 1 | 22 | 228 |
GO:0003713 | transcription coactivator activity | 1.39e-01 | 1.00e+00 | 2.757 | 1 | 24 | 237 |
GO:0016070 | RNA metabolic process | 1.44e-01 | 1.00e+00 | 2.698 | 1 | 8 | 247 |
GO:0005975 | carbohydrate metabolic process | 1.47e-01 | 1.00e+00 | 2.663 | 1 | 8 | 253 |
GO:0044281 | small molecule metabolic process | 1.71e-01 | 1.00e+00 | 1.404 | 2 | 20 | 1211 |
GO:0005737 | cytoplasm | 1.87e-01 | 1.00e+00 | 0.767 | 4 | 124 | 3767 |
GO:0008283 | cell proliferation | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 14 | 328 |
GO:0003723 | RNA binding | 1.94e-01 | 1.00e+00 | 2.228 | 1 | 18 | 342 |
GO:0046982 | protein heterodimerization activity | 2.14e-01 | 1.00e+00 | 2.076 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 2.19e-01 | 1.00e+00 | 2.035 | 1 | 15 | 391 |
GO:0009986 | cell surface | 2.25e-01 | 1.00e+00 | 1.995 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.30e-01 | 1.00e+00 | 1.956 | 1 | 24 | 413 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.33e-01 | 1.00e+00 | 1.935 | 1 | 30 | 419 |
GO:0043066 | negative regulation of apoptotic process | 2.36e-01 | 1.00e+00 | 1.918 | 1 | 16 | 424 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.62e-01 | 1.00e+00 | 1.745 | 1 | 24 | 478 |
GO:0016032 | viral process | 2.88e-01 | 1.00e+00 | 1.585 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 2.98e-01 | 1.00e+00 | 1.530 | 1 | 12 | 555 |
GO:0005789 | endoplasmic reticulum membrane | 3.04e-01 | 1.00e+00 | 1.491 | 1 | 9 | 570 |
GO:0070062 | extracellular vesicular exosome | 4.56e-01 | 1.00e+00 | 0.417 | 2 | 57 | 2400 |
GO:0005615 | extracellular space | 4.61e-01 | 1.00e+00 | 0.744 | 1 | 20 | 957 |
GO:0005524 | ATP binding | 5.72e-01 | 1.00e+00 | 0.304 | 1 | 31 | 1298 |
GO:0006351 | transcription, DNA-templated | 6.14e-01 | 1.00e+00 | 0.148 | 1 | 57 | 1446 |
GO:0005730 | nucleolus | 6.63e-01 | 1.00e+00 | -0.034 | 1 | 66 | 1641 |
GO:0005886 | plasma membrane | 8.31e-01 | 1.00e+00 | -0.688 | 1 | 49 | 2582 |